Exosomes are 30-100 nm microvesicles which contain complex cellular signals of RNA, protein and lipids. Because of this, exosomes are implicated as having limitless therapeutic potential for the treatment of cancer, pregnancy complications, infections, and autoimmune diseases. To date we know a considerable amount about exosome biogenesis and secretion, but there is a paucity of…
Journal of Circulating Biomarkers Template
Write in a clean editor, then format for Journal of Circulating Biomarkers in one click — DocuGuru applies the official SAGE template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Circulating Biomarkers format
Journal of Circulating Biomarkers is a peer-reviewed journal published by SAGE, covering Extracellular vesicles in disease, Cancer Cells and Metastasis, MicroRNA in disease regulation.
| Publisher | SAGE |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Journal of Circulating Biomarkers, 12(3), pp. 45–58.
Formats any DOI in Journal of Circulating Biomarkers style. No sign-up. |
| Publishes research in | Extracellular vesicles in disease Cancer Cells and Metastasis MicroRNA in disease regulation Cancer Genomics and Diagnostics RNA Interference and Gene Delivery |
| ISSN | 1849-4544 |
| Citation impact (2-yr) | 1.27 |
| h-index | 24 |
| i10-index | 50 |
| Total citations | 2,311 |
| Article processing charge | $1,617 |
| Open access | Yes |
| Top institutions publishing here | Epic Sciences (United States) |
| Journal website | journals.aboutscience.eu |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Circulating Biomarkers per year
Citation impact of Journal of Circulating Biomarkers by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Circulating Biomarkers
This study aimed to evaluate the effect of mesenchymal stem cells (MSCs)–derived exosomes in retina regeneration of experimentally induced diabetes mellitus (DM) in a rabbit model. Exosomes are extracellular vesicles that contain many microRNAs (micRNAs), mRNAs, and proteins from their cells of origin. DM was induced by intravenous (IV) injection of streptozotocin in rabbits. MSCs…
The Epic Platform was developed for the unbiased detection and molecular characterization of circulating tumour cells (CTCs). Here, we report assay performance data, including accuracy, linearity, specificity and intra/inter-assay precision of CTC enumeration in healthy donor (HD) blood samples spiked with varying concentrations of cancer cell line controls (CLCs). Additionally, we demonstrate clinical feasibility for…
A successful strategy in regenerative medicine\nover the last decade has been the translation of stem cell\ntherapy to repair diseased or damaged tissue in a wide\nrange of indications, despite limited evidence attributing\nany therapeutic benefit to cell survival or differentiation.\nRecent findings, however, have demonstrated that the\nconditioned media from stem cell cultures can produce\nsimilar efficacious effects compared to…
Epithelial cell adhesion molecule (EpCAM)-targeted capture remains the most common isolation strategy for circulating tumor cells (CTCs). However, epithelial-to-mesenchymal transition (EMT) leads to decreased epithelial EpCAM expression affecting the optimal CTC capture. In this study, we tested a cohort of ovarian cancer cell lines using flow cytometry to identify N-cadherin as the additional immunomagnetic cell…